Jiangsu Aidea Pharmaceutical Co Ltd (688488) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥3.56 Million ≈ $521.57K USD) by net assets (CN¥1.08 Billion ≈ $158.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Jiangsu Aidea Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.

Jiangsu Aidea Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Jiangsu Aidea Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangsu Aidea Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Aidea Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Jiangsu Aidea Pharmaceutical Co Ltd (688488) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Econergy Renewable Energy Ltd TA:ECNR	-0.003x
Piraeus Port Authority S.A AT:PPA	0.158x
WAM Capital Ltd AU:WAM	0.063x
Hyosung TNC Corp KO:298020	0.065x
Critical Metals Corp. Ordinary Shares NASDAQ:CRML	-0.067x
Shandong Intco Recycling Resources Co Ltd SHG:688087	0.063x
Shanghai AJ Group Co Ltd SHG:600643	-0.002x
Aksa Akrilik Kimya Sanayi AS IS:AKSA	0.004x

Annual Cash Flow Conversion Efficiency for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025. View 688488 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.07 Billion ≈ $157.05 Million	CN¥17.63 Million ≈ $2.58 Million	0.016x	+146.75%
2024-12-31	CN¥1.07 Billion ≈ $156.15 Million	CN¥-37.50 Million ≈ $-5.49 Million	-0.035x	+76.21%
2023-12-31	CN¥1.13 Billion ≈ $164.70 Million	CN¥-166.22 Million ≈ $-24.32 Million	-0.148x	-91.31%
2022-12-31	CN¥1.20 Billion ≈ $175.45 Million	CN¥-92.55 Million ≈ $-13.54 Million	-0.077x	-717.31%
2021-12-31	CN¥1.31 Billion ≈ $191.66 Million	CN¥-12.37 Million ≈ $-1.81 Million	-0.009x	-122.87%
2020-12-31	CN¥1.36 Billion ≈ $198.99 Million	CN¥56.17 Million ≈ $8.22 Million	0.041x	-59.12%
2019-12-31	CN¥556.24 Million ≈ $81.39 Million	CN¥56.20 Million ≈ $8.22 Million	0.101x	+257.64%
2018-12-31	CN¥522.71 Million ≈ $76.49 Million	CN¥-33.50 Million ≈ $-4.90 Million	-0.064x	+50.96%
2017-12-31	CN¥514.09 Million ≈ $75.23 Million	CN¥-67.18 Million ≈ $-9.83 Million	-0.131x	-225.46%
2016-12-31	CN¥300.40 Million ≈ $43.96 Million	CN¥31.29 Million ≈ $4.58 Million	0.104x	--

About Jiangsu Aidea Pharmaceutical Co Ltd

SHG:688488 China Biotechnology

Market Cap

$944.54 Million

CN¥6.45 Billion CNY

Market Cap Rank

#9230 Global

#2303 in China

Share Price

CN¥15.34

Change (1 day)

+0.66%

52-Week Range

CN¥11.59 - CN¥22.16

All Time High

CN¥42.39